FR2571968B1 - VIRUS PURIFIES LYMPHADENOPATHIES AND ACQUIRED IMMUNO-DEPRESSION SYNDROME AND ENVELOPE ANTIGENS OF THIS VIRUS, VIRUS AND ENVELOPE ANTIGENS OF THIS VIRUS, APPLICATIONS OF THIS VIRUS OR ANTIGENS THEREOF PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE ABOVE CONDITIONS. - Google Patents

VIRUS PURIFIES LYMPHADENOPATHIES AND ACQUIRED IMMUNO-DEPRESSION SYNDROME AND ENVELOPE ANTIGENS OF THIS VIRUS, VIRUS AND ENVELOPE ANTIGENS OF THIS VIRUS, APPLICATIONS OF THIS VIRUS OR ANTIGENS THEREOF PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE ABOVE CONDITIONS.

Info

Publication number
FR2571968B1
FR2571968B1 FR8416013A FR8416013A FR2571968B1 FR 2571968 B1 FR2571968 B1 FR 2571968B1 FR 8416013 A FR8416013 A FR 8416013A FR 8416013 A FR8416013 A FR 8416013A FR 2571968 B1 FR2571968 B1 FR 2571968B1
Authority
FR
France
Prior art keywords
virus
antigens
envelope
envelope antigens
lymphadenopathies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8416013A
Other languages
French (fr)
Other versions
FR2571968A1 (en
Inventor
Luc Montagnier
Bernard Krust
Solange Chamaret
Francois Clavel
Jean-Claude Chermann
Francoise Barre-Sinoussi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9308806&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2571968(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR8416013A priority Critical patent/FR2571968B1/en
Priority to DE3588254T priority patent/DE3588254T2/en
Priority to PCT/EP1985/000548 priority patent/WO1986002383A1/en
Priority to EP04077731A priority patent/EP1568767A2/en
Priority to AT90105190T priority patent/ATE86636T1/en
Priority to DE9090105190T priority patent/DE3587181T2/en
Priority to PT81338A priority patent/PT81338B/en
Priority to AT90105189T priority patent/ATE92502T1/en
Priority to DE8585905513T priority patent/DE3583293D1/en
Priority to AT02008713T priority patent/ATE286132T1/en
Priority to IE258785A priority patent/IE64006B1/en
Priority to JP60504853A priority patent/JP2609448B2/en
Priority to EP02008713A priority patent/EP1231271B2/en
Priority to KR1019860700374A priority patent/KR930000189B1/en
Priority to DE3588248T priority patent/DE3588248T2/en
Priority to EP02017001A priority patent/EP1279678B1/en
Priority to EP91113062A priority patent/EP0462627B2/en
Priority to AT02017001T priority patent/ATE373010T1/en
Priority to DE3588251T priority patent/DE3588251T2/en
Priority to AT85905513T priority patent/ATE64601T1/en
Priority to AT91113062T priority patent/ATE250083T1/en
Priority to CA493377A priority patent/CA1341620C/en
Priority to ES548048A priority patent/ES8705522A1/en
Priority to AU50617/85A priority patent/AU603543B2/en
Priority to DE90105189T priority patent/DE3587512T2/en
Priority to EP90105189A priority patent/EP0387914B1/en
Priority to NZ230372A priority patent/NZ230372A/en
Priority to EP90105190A priority patent/EP0387915B1/en
Priority to ZA858034A priority patent/ZA858034B/en
Priority to EP85905513A priority patent/EP0201540B2/en
Priority to GR852522A priority patent/GR852522B/el
Priority to DE200512000039 priority patent/DE122005000039I1/en
Publication of FR2571968A1 publication Critical patent/FR2571968A1/en
Priority to DK198602849A priority patent/DK174910B1/en
Priority to ES557358A priority patent/ES8801319A1/en
Priority to ES557357A priority patent/ES8801318A1/en
Priority to US07/158,652 priority patent/US7217508B1/en
Application granted granted Critical
Publication of FR2571968B1 publication Critical patent/FR2571968B1/en
Priority to US07/751,059 priority patent/US5980900A/en
Priority to US08/026,736 priority patent/US7045130B1/en
Priority to DK199300355A priority patent/DK172814B1/en
Priority to US08/156,930 priority patent/US7351412B1/en
Priority to US08/195,024 priority patent/US5705612A/en
Priority to US08/308,219 priority patent/US7232654B1/en
Priority to US08/308,218 priority patent/US7119181B1/en
Priority to US08/313,572 priority patent/US5610035A/en
Priority to JP6329052A priority patent/JP2752329B2/en
Priority to US08/475,822 priority patent/US7205102B1/en
Priority to JP8218963A priority patent/JP2971034B2/en
Priority to JP8218964A priority patent/JP2761376B2/en
Priority to JP8290839A priority patent/JP2777115B2/en
Priority to US09/344,449 priority patent/US6261564B1/en
Priority to US09/709,316 priority patent/US6706268B1/en
Priority to HK03100877.5A priority patent/HK1050215B/en
Priority to HK03104359A priority patent/HK1053662A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR8416013A 1983-09-15 1984-10-18 VIRUS PURIFIES LYMPHADENOPATHIES AND ACQUIRED IMMUNO-DEPRESSION SYNDROME AND ENVELOPE ANTIGENS OF THIS VIRUS, VIRUS AND ENVELOPE ANTIGENS OF THIS VIRUS, APPLICATIONS OF THIS VIRUS OR ANTIGENS THEREOF PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE ABOVE CONDITIONS. Expired FR2571968B1 (en)

Priority Applications (53)

Application Number Priority Date Filing Date Title
FR8416013A FR2571968B1 (en) 1984-10-18 1984-10-18 VIRUS PURIFIES LYMPHADENOPATHIES AND ACQUIRED IMMUNO-DEPRESSION SYNDROME AND ENVELOPE ANTIGENS OF THIS VIRUS, VIRUS AND ENVELOPE ANTIGENS OF THIS VIRUS, APPLICATIONS OF THIS VIRUS OR ANTIGENS THEREOF PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE ABOVE CONDITIONS.
DE3588254T DE3588254T2 (en) 1984-10-18 1985-10-18 GAG antigen and its use for the detection of LAV infection, as well as in immunogenic compositions
PCT/EP1985/000548 WO1986002383A1 (en) 1984-10-18 1985-10-18 Envelope antigens of lymphadenopathy associated virus and their applications
EP04077731A EP1568767A2 (en) 1984-10-18 1985-10-18 Dna fragments of lav genes
AT90105190T ATE86636T1 (en) 1984-10-18 1985-10-18 F ANTIGENS OF HUMAN IMMUNODEFICIENCY VIRUS AND THEIR USES.
DE9090105190T DE3587181T2 (en) 1984-10-18 1985-10-18 F ANTIGENS OF THE HUMAN IMMUNODEFICIENCY VIRUS AND THEIR USE.
PT81338A PT81338B (en) 1984-10-18 1985-10-18 ANTIGEN, IN PARTICULAR ANTIGEN OF THE INVOLVEMENT OF THE LINFOADENOPATHY VIRUS AND THE IMMUNO-DEFICIENCY SYNDROME ACQUIRED, AND VIRUS, PROCESS FOR PRODUCING VIRUS SURFACES ANTIGEN, USING THESE ANTIGENS IN THE PREPARATION OF IMMUNOGENIC COMPOSITIONS OR IN THE DIAGNOSIS OF THE PRESENCE OF ANTIBODIES AGAINST THIS VIRUS
AT90105189T ATE92502T1 (en) 1984-10-18 1985-10-18 ENVELOPE ANTIGENS OF HUMAN IMMUNODEFICIENCY VIRUS AND THEIR USES.
DE8585905513T DE3583293D1 (en) 1984-10-18 1985-10-18 LYMPHADENOPATHY-ASSOCIATED SHELL ANTIGENS AND THEIR USE.
AT02008713T ATE286132T1 (en) 1984-10-18 1985-10-18 DNA FRAGMENTS OF THE LAV GAG GENE
IE258785A IE64006B1 (en) 1984-10-18 1985-10-18 Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus
JP60504853A JP2609448B2 (en) 1984-10-18 1985-10-18 Viral envelope antigens of lymphadenopathy and acquired immunodeficiency syndrome
EP02008713A EP1231271B2 (en) 1984-10-18 1985-10-18 DNA fragments of the GAG gene of LAV
KR1019860700374A KR930000189B1 (en) 1984-10-18 1985-10-18 Envelope antigens of lymphadenopathy associated virus
DE3588248T DE3588248T2 (en) 1984-10-18 1985-10-18 LAV antigens and peptides
EP02017001A EP1279678B1 (en) 1984-10-18 1985-10-18 Gag antigen and its use for the detection of lav infection and in immunogenic compositions
EP91113062A EP0462627B2 (en) 1984-10-18 1985-10-18 Antigens and peptides of lav.
AT02017001T ATE373010T1 (en) 1984-10-18 1985-10-18 GAG ANTIGEN AND ITS USE FOR DETECTING LAV INFECTION, AND IN IMMUNOGENIC COMPOSITIONS
DE3588251T DE3588251T2 (en) 1984-10-18 1985-10-18 DNA fragments of the GAG gene of LAV
AT85905513T ATE64601T1 (en) 1984-10-18 1985-10-18 LYMPHADENOPATHY-ASSOCIATED ENVELOPE ANTIGENS AND THEIR USES.
AT91113062T ATE250083T1 (en) 1984-10-18 1985-10-18 LAV ANTIGENS AND PEPTIDES
CA493377A CA1341620C (en) 1984-10-18 1985-10-18 Envelope antigens of hiv-1
ES548048A ES8705522A1 (en) 1984-10-18 1985-10-18 Gag antigen and its use for the detection of lav infection and in immunogenic compositions
AU50617/85A AU603543B2 (en) 1984-10-18 1985-10-18 Envelope antigens of lymphadenopathy associated virus and their applications
DE90105189T DE3587512T2 (en) 1984-10-18 1985-10-18 Envelope antigens from the human immunodeficiency virus and their uses.
EP90105189A EP0387914B1 (en) 1984-10-18 1985-10-18 Envelope antigens of the human immuno-deficiency virus, and their applications
NZ230372A NZ230372A (en) 1984-10-18 1985-10-18 Hiv antigen, assay and vaccine.
EP90105190A EP0387915B1 (en) 1984-10-18 1985-10-18 F antigens of the human immunodeficiency virus, and their applications
ZA858034A ZA858034B (en) 1984-10-18 1985-10-18 Antigens
EP85905513A EP0201540B2 (en) 1984-10-18 1985-10-18 Envelope antigens of lymphadenopathy associated virus and their applications
GR852522A GR852522B (en) 1984-10-18 1985-10-18
DE200512000039 DE122005000039I1 (en) 1984-10-18 1985-10-18 DNA fragments of the GAG gene of LAV
DK198602849A DK174910B1 (en) 1984-10-18 1986-06-18 Antigen, method of preparation of antigen, method of diagnosis and immunogenic preparations
ES557358A ES8801319A1 (en) 1984-10-18 1987-01-08 Gag antigen and its use for the detection of lav infection and in immunogenic compositions
ES557357A ES8801318A1 (en) 1984-10-18 1987-01-08 Gag antigen and its use for the detection of lav infection and in immunogenic compositions
US07/158,652 US7217508B1 (en) 1983-09-15 1988-02-22 Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1)
US07/751,059 US5980900A (en) 1984-10-18 1991-08-28 Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus (HIV-1)
US08/026,736 US7045130B1 (en) 1984-10-18 1993-03-05 Antibodies against antigens of human immunodeficiency virus (HIV-1)
DK199300355A DK172814B1 (en) 1984-10-18 1993-03-26 Antigens encoded by the gag open reading frame for LAV virus, use thereof in the preparation
US08/156,930 US7351412B1 (en) 1983-12-05 1993-11-24 Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA
US08/195,024 US5705612A (en) 1984-10-18 1994-02-14 NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)
US08/308,219 US7232654B1 (en) 1983-09-15 1994-09-19 DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1)
US08/308,218 US7119181B1 (en) 1984-10-18 1994-09-19 DNA sequences and peptides of human immunodeficiency virus (HIV-1)
US08/313,572 US5610035A (en) 1983-12-05 1994-09-27 Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies
JP6329052A JP2752329B2 (en) 1984-10-18 1994-12-28 Method for producing envelope antigen of virus of lymphadenopathy and acquired immunodeficiency syndrome
US08/475,822 US7205102B1 (en) 1983-09-15 1995-06-07 Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA
JP8218963A JP2971034B2 (en) 1984-10-18 1996-08-20 Antigen of lymphadenopathy / acquired immunodeficiency syndrome virus
JP8218964A JP2761376B2 (en) 1984-10-18 1996-08-20 Antigen of lymphadenopathy / acquired immunodeficiency syndrome virus
JP8290839A JP2777115B2 (en) 1984-10-18 1996-10-31 Methods for detecting anti-LAV virus antibodies in biological fluids
US09/344,449 US6261564B1 (en) 1984-10-18 1997-12-31 Peptides of human immunodeficiency virus type 1 (HIV-1)
US09/709,316 US6706268B1 (en) 1984-10-18 2000-11-13 Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene
HK03100877.5A HK1050215B (en) 1984-10-18 2003-02-06 Dna fragments of the gag gene of lav
HK03104359A HK1053662A1 (en) 1984-10-18 2003-06-17 Gag antigen and its use for the detection of lav infection and in immunogenic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8416013A FR2571968B1 (en) 1984-10-18 1984-10-18 VIRUS PURIFIES LYMPHADENOPATHIES AND ACQUIRED IMMUNO-DEPRESSION SYNDROME AND ENVELOPE ANTIGENS OF THIS VIRUS, VIRUS AND ENVELOPE ANTIGENS OF THIS VIRUS, APPLICATIONS OF THIS VIRUS OR ANTIGENS THEREOF PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE ABOVE CONDITIONS.

Publications (2)

Publication Number Publication Date
FR2571968A1 FR2571968A1 (en) 1986-04-25
FR2571968B1 true FR2571968B1 (en) 1989-03-17

Family

ID=9308806

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8416013A Expired FR2571968B1 (en) 1983-09-15 1984-10-18 VIRUS PURIFIES LYMPHADENOPATHIES AND ACQUIRED IMMUNO-DEPRESSION SYNDROME AND ENVELOPE ANTIGENS OF THIS VIRUS, VIRUS AND ENVELOPE ANTIGENS OF THIS VIRUS, APPLICATIONS OF THIS VIRUS OR ANTIGENS THEREOF PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE ABOVE CONDITIONS.

Country Status (3)

Country Link
JP (1) JP2609448B2 (en)
FR (1) FR2571968B1 (en)
ZA (1) ZA858034B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
ATE116006T1 (en) 1985-04-29 1995-01-15 Genetic Systems Corp SYNTHETIC ANTIGENS FOR DETECTING AIDS.
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals

Also Published As

Publication number Publication date
JPS62500592A (en) 1987-03-12
FR2571968A1 (en) 1986-04-25
ZA858034B (en) 1986-06-25
JP2609448B2 (en) 1997-05-14

Similar Documents

Publication Publication Date Title
OA06719A (en) New oximes derived from erythromycin A, their preparation, their application as medicaments and the pharmaceutical compositions containing them.
FR2580177B2 (en) AIDS VIRUS ENVELOPE GLYCOPROTEIN-RELATED ANTIGENS, IN PARTICULAR PRECURSORS OF SUCH GLYCOPROTEIN, PROCESSES FOR OBTAINING SUCH ANTIGENS, AND MEANS USED IN SUCH PROCESSES, APPLICATIONS OF SUCH ANTIGENS TO THE PREPARATION OF IMMUNOGEN COMPOSITIONS AIDS OR RELATED CONDITIONS
AU7546887A (en) Variants of lav viruses, their dna- and protein-components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions
FR2686097B1 (en) PREPARATION OF ANTIGENS AND MYSTERY DISEASE VIRUS VACCINES, ANTIGENS AND VACCINES OBTAINED FOR THE PREVENTION OF THIS DISEASE.
FR2596393B1 (en) HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
ES509307A0 (en) "IMPROVEMENTS IN THE REALIZATION OF CONSTRUCTION ROTOR BLADES IN CASCARA".
FR2723740B1 (en) PROCESS FOR THE PREPARATION OF INFLUENZA VIRUS ANTIGENS, ANTIGENS OBTAINED AND THEIR APPLICATIONS
IT1212778B (en) PHARMACEUTICAL COMPOSITIONS ANTI-INFLAMMATORY AND / OR ANALGESIC ADAPTERITY, NON ULCEROGENE.
ES512087A0 (en) "PREPARATION PROCEDURE FOR HIGH MOLECULAR WEIGHT ORGANOPOLISILOXANES".
FR2571968B1 (en) VIRUS PURIFIES LYMPHADENOPATHIES AND ACQUIRED IMMUNO-DEPRESSION SYNDROME AND ENVELOPE ANTIGENS OF THIS VIRUS, VIRUS AND ENVELOPE ANTIGENS OF THIS VIRUS, APPLICATIONS OF THIS VIRUS OR ANTIGENS THEREOF PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE ABOVE CONDITIONS.
IT8220410A0 (en) CERAMIC FILTER, PROCEDURE FOR ITS MANUFACTURE, AS WELL AS USE OF THE FILTER.
MA19882A1 (en) Derivatives of w-amino acids, their preparation and use as well as the compositions containing these acids.
ES515671A0 (en) "PROCEDURE FOR THE PREPARATION AND PURIFICATION OF 1,2-DICHLOROETHANE".
ES510730A0 (en) "PROCEDURE FOR THE PREPARATION OF (2,2 ') - DITIAZOLYL DISULFURES".
PT79718A (en) NEW BENZIMIDAZOLE, THEIR PREPARATION AND MEDICAMENT CONTAINING THESE COMPOUNDS
ES510296A0 (en) "INTEGRAL STEAM GENERATOR-GASIFIER SYSTEM".
DE3380923D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS.
BR7409109D0 (en) CONDENSATION PRODUCTS OF O-PHENYLENODYAMINE OR 1,8-DIAMINONAFTALENE AND 4,10-BENZOTIOXANTHEN-3.1'-DICARBOXYLIC ACID ANHYDRATE ITS PREPARATION AND EMPLOYMENT
OA07558A (en) New dichlorinated derivatives of the 16 @ - methyl pregnane series, their preparation, their application as medicaments and the compositions containing them.
OA08630A (en) Immunogenic fraction active against schistosomiasis, its preparation, immunizing compositions containing it.
NO871190D0 (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE SUBSTITUTED ANILIDES.
NO158299C (en) ANALOGUE PROCEDURE FOR PREPARATION OF 17,18-DEHYDRO-APOVINCAMINOL-L-3 ', 4', 5'-TRIMETHOXY-BENZOATE.
EP0104445A3 (en) Piperidinoquinoxaline derivatives, their preparation and use
IT8219486A0 (en) NEW COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
FR2600888B1 (en) FOOD PREPARATIONS COMPRISING SALBUTAMOL, THEIR MANUFACTURING PROCESS AND THEIR USE FOR IMPROVING THE RATE OR SPEED OF GROWTH IN ANIMALS.

Legal Events

Date Code Title Description
CD Change of name or company name
CL Concession to grant licences